Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: George Soros, Paulson & Co., AbbVie Inc (ABBV), Seagate Technology PLC (STX), Alliance Data Systems Co. (ADS), and More

George Soros Bought These 2 Healthcare Stocks in the Third Quarter (The Motley Fool)
Although billionaire superinvestor George Soros may no longer be running the day-to-day operations of his namesake fund “Soros Fund Management,” the fund’s quarterly activity remains a hotbed of interest among investors and for good reason. Until only a few years ago, after all, the Soros Fund Management was the most successful hedge fund in the business. So what has the Soros Fund been buying lately? During the course of the third quarter, the recently filed 13Fs with the Securities and Exchange Commission reveal that the fund boosted its already-sizable stake in the pharmacy benefits manager Express Scripts Holding Co. (NASDAQ:ESRX) and it opened a smallish position in the Chinese cancer company Zai Lab Limited (NASDAQ:ZLAB).

UPDATE 1-ISS Backs Detour Gold Board Proposals in Paulson Proxy Fight (Reuters)
Dec 3 (Reuters) – Institutional Shareholder Services Inc (ISS) has advised shareholders to vote for Detour Gold Corp’s refreshed board of directors at an upcoming special shareholders’ meeting, stopping short of more aggressive changes demanded by activist investor Paulson & Co., the company said on Monday. Detour’s existing management has been resisting Paulson’s call for a complete overall of the board and immediate dismissal of interim Chief Executive Officer Michael Kenyon and board member Alex Morrison.

insider trading insider buys

Chad McDermott /

Sirios Capital Management L.P. Lowers Holdings in TechnipFMC PLC (FTI) (
Sirios Capital Management L.P. cut its position in TechnipFMC PLC (NYSE:FTI) by 5.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 461,521 shares of the oil and gas company’s stock after selling 24,321 shares during the quarter. Sirios Capital Management L P owned about 0.10% of TechnipFMC worth $14,423,000 at the end of the most recent reporting period.

Jeffrey Talpins: The Hedge Fund King You’ve Never Heard Of (
Jeffrey Talpins may be the hottest investor on Wall Street. His firm, Element Capital Management, posted a gain of 26.8% through October, investors say, dwarfing the 1.86% loss suffered by the average hedge fund, according to data-tracker HFR. Element has posted average gains of nearly 21% since launching 13 years ago and hasn’t suffered a down year. Talpins is a “macro” trader who uses options to try to capture the upside of – and limit potential losses from – strategies aimed at anticipating global economic shifts. Paying for stock and bond options can lead to losses in placid markets, but volatility over the past year has buoyed Element’s bullish wagers on US stocks and the US dollar. Talpin’s bearish bets on US interest rates and the euro also have paid off.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.